EMA’s human medicines committee (CHMP) has recommended granting a conditional marketing authorisation to Veklury (remdesivir) for the treatment of COVID-19 in adults and adolescents from 12 years of age with pneumonia who require supplemental oxygen.
Levels of an antibody found in recovered COVID-19 patients fell sharply in 2-3 months after infection for both symptomatic and asymptomatic patients, according to a Chinese study.
Important scientific questions have been raised about data reported in the paper by Mandeep Mehra et al—Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis.
Ten people, from seven different high-volume helicopter medical emergency services (HEMS) from five different countries collaborated to make an article about Covid-19; support tools and guidelines.
Transmission of Coronavirus disease 2019 (COVID-19) within families and
close contacts accounts for the majority of epidemic growth.
The COVID-19 pandemic poses a challenge to critical care retrieval systems, which often depend on small teams of specialists who live and work together closely.